Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass

• Κύριοι συγγραφείς: Shvetank Agarwal (Συγγραφέας), Beth Ullom (Συγγραφέας), Yasser Al-Baghdadi (Συγγραφέας), Michael Okumura (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Wolters Kluwer Medknow Publications, 2012-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Use of argatroban as an alternative to heparin during cardiopulmonary bypass (CPB) in patients with heparin-induced thrombocytopenia has gained some attention in the past two decades. Dosing of argatroban during CPB is complex due to lack of complete understanding of its pharmacokinetic profile and...